Quantification of Entacapone in Human Plasma by HPLC Coupled to ESI-MS/MS Detection: Application to Bioequavalence Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The proposed method is simple, sensitive and specific Liquid chromatography-tandem mass spectrometry (LCESI- MS/MS) method for the quantification of Entacapone (EA) in human plasma using Entacapone-d10 (EAD10) as an internal standard (IS). Chromatographic separation was performed on Zorbax SB-C18, 2.1 × 50 mm, 5 μm column, mobile phase composed of 10 mM Ammonium formate (pH 3.0): Acetonitrile (60:40 v/v), with a flow-rate of 0.7 mL/min, followed by Liquid-liquid extraction. EA and EAD10 were detected with proton adducts at m/z 306.1 → 233.1 and 316.3 → 233.0 in multiple reaction monitoring (MRM) positive mode respectively. The method was validated over a linear concentration range of 1.00 - 2000.00ng/mL with correlation coefficient (r2) ≥ 0.9993. Intra and inter-day Precision within 3.60 to 7.30 and 4.20 to 5.50% and Accuracy within 97.30 to 104.20 and 98.30 to 105.80% proved for EA. This method is successfully applied in the bioequivalence study of healthy Indian human volunteers.
Abstract
The proposed method is simple, sensitive and specific Liquid chromatography-tandem mass spectrometry (LCESI- MS/MS) method for the quantification of Entacapone (EA) in human plasma using Entacapone-d10 (EAD10) as an internal standard (IS). Chromatographic separation was performed on Zorbax SB-C18, 2.1 × 50 mm, 5 μm column, mobile phase composed of 10 mM Ammonium formate (pH 3.0): Acetonitrile (60:40 v/v), with a flow-rate of 0.7 mL/min, followed by Liquid-liquid extraction. EA and EAD10 were detected with proton adducts at m/z 306.1 → 233.1 and 316.3 → 233.0 in multiple reaction monitoring (MRM) positive mode respectively. The method was validated over a linear concentration range of 1.00 - 2000.00ng/mL with correlation coefficient (r2) ≥ 0.9993. Intra and inter-day Precision within 3.60 to 7.30 and 4.20 to 5.50% and Accuracy within 97.30 to 104.20 and 98.30 to 105.80% proved for EA. This method is successfully applied in the bioequivalence study of healthy Indian human volunteers.
참고문헌 (11)
- Physician’s Desk Reference (PDR), "Product monograph for comtan®", 2186~ (2006)
- Yadav, M., , J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 877(5), pp.533~ (2009)
- Doshi, A. S., , J. AOAC, 92(2), pp.394~ (2009)
- Ramakrishna, N. V. S., , J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 823(2), pp.189~ (2005)
- Keski-Hynnila, H., , Anal. Chem., 74(14), pp.3449~ (2002)
- Tuomainen, P., , J. Pharm. Biomed. Anal., 14(5), pp.515~ (1996)
- Wikberg, T., , Eur. J. Drug Metab. Pharmacokinet., 18(4), pp.359~ (1993)
- Wikberg, T., , Drug Metab. Dispos., 21(1), pp.81~ (1993)
- Karlsson, M., , J. Pharm. Biomed. Anal., 10(8), pp.593~ (1992)
- Hakala, K. S., , Anal. Biochem., 341(1), pp.105~ (2005)
- "Guidance for industry: bioanalytical method validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER)", ~ (2001)